Format

Send to

Choose Destination
Bull Exp Biol Med. 2015 Sep;159(5):685-8. doi: 10.1007/s10517-015-3047-x. Epub 2015 Oct 15.

Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology.

Author information

1
Research Institute of Pulmonology, I. P. Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia.
2
Research Institute of Pulmonology, I. P. Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia. osmelena@mail.ru.

Abstract

On the model of chronic obstructive pulmonary disease, the effect of therapy with low-molecular-weight peptides on restructuring and functional activity of bronchial epithelium for restoring the immune and barrier function of the lungs and prevention of inflammatory process progression was studied. Chronic obstructive pulmonary disease was modeled in rats by 60-day intermittent exposure to NO2. Administration of tetrapeptide Bronchogen for 1 month eliminates symptoms of remodeling of the bronchial epithelium and lung tissue typical of chronic obstructive pulmonary disease (goblet cell hyperplasia, squamous metaplasia, lymphocytic infiltration and emphysema, and restoration of ciliated cells). Enhanced production of secretory IgA, a local immunity marker, attested to normalization of functional activity of bronchial epithelium, while normalization of cell composition and profile of proinflammatory cytokines in the bronchoalveolar space reflected reduction of neutrophilic inflammation.

KEYWORDS:

bronchial epithelium; chronic obstructive pulmonary disease; regulatory peptides, inflammation

PMID:
26468022
DOI:
10.1007/s10517-015-3047-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center